Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

Gemma Atkinson has revealed that she has no plans to take part in another soap opera, citing the impact their hectic filming schedules would have on raising her children. The mother-of-two shares ...

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Actress Gemma Atkinson has decisively shut the door on a return to her soap opera beginnings. The star, who initially rose to fame as Lisa Hunter on Channel 4's Hollyoaks from 2001 to 2005 and ...

Gemma Atkinson has admitted she hasn't completely given up on acting, and addressed a potential return to the world of soap operas. The 40-year-old is now best known for her presenting roles, co ...

It is tailored to patients being treated with Lilly's oncology drugs – which include blockbuster CDK 4/ 6 inhibitor Verzenio (abemaciclib) for hormone receptor-positive, HER2-negative breast ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...